Latest Announcements

BSE & NSE corporate filings with AI summaries

BSEBoard MeetingResults30 Jul 2026

Orosil Smiths India Ltd-$

Orosil Smiths India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve as per enclosed

Orosil Smiths India Ltd has informed BSE that the meeting of the Board of Directors is scheduled on August 10, 2026, to consider and approve the Un-audited Standalone Financial Results for the first quarter ended June 30, 2026, and to fix the date for the ensuing Annual General Meeting.

Read more →📎 1 attachment
BSEBoard MeetingResults30 Jul 2026

Simandhar Impex Ltd

Simandhar Impex Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and approve 1. the Unaudited Standalone ....

Simandhar Impex Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 to consider and approve the Unaudited Standalone Financial Results of the Company for the quarter ended 30th June, 2026.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults30 Jul 2026

Laurus Labs Limited

Analysts/Institutional Investor Meet/Con. Call Updates

Laurus Labs Limited has hosted a Q1 FY27 earnings conference call, discussing strong growth momentum, with revenue of INR2,026 crores, a 29% growth, and EBITDA margins expanding to 31.8%. The company has also signed a development and commercial agreement with Aarvik Therapeutics for 2 ADC molecules and onboarded a big pharma client.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults30 Jul 2026

Laurus Labs Ltd

Please see annexed enclosure.

Laurus Labs Ltd reported Q1 FY27 earnings, with revenue of INR2,026 crores, a 29% growth, driven by commercial supplies in CDMO segment and continued strength in affordable medicine portfolio. Gross margins were healthy at 62.7%, and EBITDA margins expanded to 31.8%. The company signed a development and commercial agreement with Aarvik Therapeutics for 2 ADC molecules for India markets, and onboarded a big pharma client with significant opportunities ahead.

Read more →📎 1 attachment
BSEOthersResults30 Jul 2026

Shiva Texyarn Ltd

Annual Report 2026

Shiva Texyarn Ltd has submitted its Annual Report for the financial year 2025-26, as per Regulation 34(1) of SEBI (Listing Obligations and Disclosure Requirements), 2015. The report has been uploaded on the company's website. The report includes the Board of Directors, Directors' Report, Corporate Governance Report, Management Discussion and Analysis, and Standalone Financial Statements.

Read more →📎 1 attachment
BSECompany UpdateResults30 Jul 2026

Hawkins Cookers Ltd-$

As required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, copies of the Extract of the Unaudited Financial Results for the quarter ....

Hawkins Cookers Ltd. has published its unaudited financial results for the quarter ended June 30, 2026, showing a total income of Rs. 318.13 crores, a net profit before tax of Rs. 40.87 crores, and an earnings per share of Rs. 57.45.

Read more →📎 1 attachment
BSEBoard MeetingResults30 Jul 2026

Gujarat Pipavav Port Ltd

Gujarat Pipavav Port Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Intimation regarding the ....

Gujarat Pipavav Port Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 12/08/2026 to consider and approve unaudited standalone and consolidated financial results for the quarter ended 30/06/2026.

Read more →📎 1 attachment
BSECompany UpdateResults30 Jul 2026

Gujarat Alkalies and Chemicals Ltd

We are enclosing herewith Credit Rating reports issued by CARE Ratings Limited. For more details kindly refer attached file.

Gujarat Alkalies and Chemicals Ltd has received credit ratings from CARE Ratings Limited for its bank facilities. The ratings are as follows: Long Term Bank Facilities: CARE AA-; Stable (downgraded from CARE AA; Stable), Short Term Bank Facilities: CARE A1+ Reaffirmed. The ratings are based on the company's recent developments, including its operational and financial performance for FY26 (Audited) and Q1FY27 (Unaudited).

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults30 Jul 2026

Rossell Techsys Limited

Press Release

Rossell Techsys Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations surging 78% year-on-year to ₹154.7 crore, and profit before tax (PBT) soaring 139% year-on-year to ₹9.60 crore.

Read more →📎 1 attachment
← PreviousPage 1842 of 2375Next →